| Cancer | Chr | Position | Mutation Type | dbSNP | Protein-change | Allele Freq | RBD |
|---|---|---|---|---|---|---|---|
| BLCA | |||||||
| BLCA | |||||||
| BLCA | |||||||
| BLCA | |||||||
| BLCA | |||||||
| BRCA | |||||||
| BRCA | |||||||
| BRCA | |||||||
| BRCA | |||||||
| CESC | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| COAD | |||||||
| ESCA | |||||||
| ESCA | |||||||
| ESCA | |||||||
| GBM | |||||||
| GBM | |||||||
| HNSC | |||||||
| HNSC | |||||||
| KIRC | |||||||
| KIRP | |||||||
| LIHC | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUAD | |||||||
| LUSC | |||||||
| LUSC | |||||||
| LUSC | |||||||
| LUSC | |||||||
| OV | |||||||
| OV | |||||||
| PRAD | |||||||
| PRAD | |||||||
| READ | |||||||
| SARC | |||||||
| SKCM | |||||||
| SKCM | |||||||
| SKCM | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| STAD | |||||||
| THYM | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC | |||||||
| UCEC |
| Cancer | Type | Freq | Q-value |
|---|---|---|---|
| KIRP | |||
| PAAD | |||
| READ |
| Cancer | P-value | Q-value |
|---|---|---|
| THYM | ||
| KIRC | ||
| ACC | ||
| KIRP | ||
| PAAD | ||
| LAML | ||
| KICH | ||
| GBM | ||
| LGG | ||
| CHOL | ||
| UVM | ||
| OV |
| Transcript ID | Name | Length | RefSeq ID | Protein ID | Length | RefSeq ID | UniportKB ID |
|---|---|---|---|---|---|---|---|
| ENST00000409920 | ANXA4-202 | 1414 | - | ENSP00000386756 | 299 (aa) | - | Q6P452 |
| ENST00000477632 | ANXA4-209 | 3949 | - | - | - (aa) | - | - |
| ENST00000418066 | ANXA4-203 | 905 | - | - | - (aa) | - | - |
| ENST00000471395 | ANXA4-207 | 4418 | - | - | - (aa) | - | - |
| ENST00000394295 | ANXA4-201 | 2799 | XM_017003943 | ENSP00000377833 | 321 (aa) | XP_016859432 | P09525 |
| ENST00000460439 | ANXA4-204 | 543 | - | - | - (aa) | - | - |
| ENST00000468815 | ANXA4-206 | 521 | - | ENSP00000489490 | 8 (aa) | - | A0A0U1RRE7 |
| ENST00000487351 | ANXA4-211 | 552 | - | - | - (aa) | - | - |
| ENST00000472124 | ANXA4-208 | 376 | - | ENSP00000489464 | 7 (aa) | - | A0A1Y8EKW3 |
| ENST00000460942 | ANXA4-205 | 576 | - | - | - (aa) | - | - |
| ENST00000635311 | ANXA4-212 | 1492 | - | ENSP00000489316 | 142 (aa) | - | B4E1S2 |
| ENST00000484219 | ANXA4-210 | 338 | - | - | - (aa) | - | - |
| ensgID | SNP | Chromosome | Position | SNP-risk | Trait | PubmedID | 95% CI | Or or BEAT | EFO ID |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000196975 | rs7597155 | 2 | 69758303 | A | Palmitoleic acid (16:1n-7) levels | 23362303 | unit increase | 0.0149 | EFO_0005110 |
| ENSG00000196975 | rs62133983 | 2 | 69749252 | G | Atrial fibrillation | 28416818 | [1.06-1.12] | 1.09 | EFO_0000275 |
| ENSG00000196975 | rs6546550 | 2 | 69811100 | C | Prevalent atrial fibrillation | 28416818 | 1.08-1.16 | 1.12 | EFO_0000275 |

| Go ID | Go_term | PubmedID | Evidence | Category |
|---|---|---|---|---|
| GO:0004859 | phospholipase inhibitor activity | 2970257. | NAS | Function |
| GO:0005509 | calcium ion binding | 21873635. | IBA | Function |
| GO:0005509 | calcium ion binding | 20237821. | IDA | Function |
| GO:0005515 | protein binding | 21873635. | IBA | Function |
| GO:0005515 | protein binding | 21044950. | IPI | Function |
| GO:0005544 | calcium-dependent phospholipid binding | 2138016. | IDA | Function |
| GO:0005544 | calcium-dependent phospholipid binding | 2970257. | NAS | Function |
| GO:0005634 | nucleus | 21873635. | IBA | Component |
| GO:0005634 | nucleus | 16687573.20237821. | IDA | Component |
| GO:0005737 | cytoplasm | 21873635. | IBA | Component |
| GO:0005737 | cytoplasm | 20237821. | IDA | Component |
| GO:0005737 | cytoplasm | 16130169. | TAS | Component |
| GO:0005829 | cytosol | 21873635. | IBA | Component |
| GO:0005886 | plasma membrane | 21873635. | IBA | Component |
| GO:0005886 | plasma membrane | 16687573. | IDA | Component |
| GO:0006357 | regulation of transcription by RNA polymerase II | 20237821. | IDA | Process |
| GO:0007165 | signal transduction | 16130169. | TAS | Process |
| GO:0007219 | Notch signaling pathway | 21873635. | IBA | Process |
| GO:0008201 | heparin binding | 21873635. | IBA | Function |
| GO:0009986 | cell surface | 22056994. | IDA | Component |
| GO:0012506 | vesicle membrane | 16687573. | IDA | Component |
| GO:0030855 | epithelial cell differentiation | 21873635. | IBA | Process |
| GO:0030855 | epithelial cell differentiation | 21492153. | IEP | Process |
| GO:0031965 | nuclear membrane | 16687573. | IDA | Component |
| GO:0032088 | negative regulation of NF-kappaB transcription factor activity | 20237821. | IDA | Process |
| GO:0035374 | chondroitin sulfate binding | 21873635. | IBA | Function |
| GO:0042802 | identical protein binding | 21873635. | IBA | Function |
| GO:0042802 | identical protein binding | 16687573. | IPI | Function |
| GO:0043066 | negative regulation of apoptotic process | 16130169. | TAS | Process |
| GO:0043086 | negative regulation of catalytic activity | - | IEA | Process |
| GO:0048306 | calcium-dependent protein binding | 21873635. | IBA | Function |
| GO:0048306 | calcium-dependent protein binding | 15226301.20237821. | IPI | Function |
| GO:0048471 | perinuclear region of cytoplasm | 16687573. | IDA | Component |
| GO:0051059 | NF-kappaB binding | 20237821. | IPI | Function |
| GO:0062023 | collagen-containing extracellular matrix | 25037231.28675934. | HDA | Component |
| GO:0070062 | extracellular exosome | 19056867.19199708.20458337.23533145. | HDA | Component |
| GO:2000483 | negative regulation of interleukin-8 secretion | 22056994. | IMP | Process |